Method for the prevention of restenosis

• US 4,824,436 A
• Filed: 04/21/1987
• Issued: 04/25/1989
• Est. Priority Date: 04/09/1985
• Status: Expired due to Fees

• Current Assignee: Harvey Wolinsky
• Original Assignee: Harvey Wolinsky
• Inventors: Wolinsky, Harvey
• Primary Examiner(s): Truluck, Dalton L.
• Application Number:
  US07/042,569
• Time in Patent Office: 735 Days
• Field of Search: 604/52-53, 604/101, 604/102, 128/344, 128/348.1
• US Class Current: 604/509
• CPC Class Codes: A61B 17/22 Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for dilators A61M29/00
• CPC Class Codes: A61M 2025/1052 for temporarily occluding a vessel for isolating a sector
• CPC Class Codes: A61M 25/1011 Multiple balloon catheters
• CPC Class Codes: A61M 25/104 used for angioplasty

Abstract

Process for local administration of heparin or other agents to inhibit arterial smooth muscle cell proliferation utilizing a catheter.

Claims

1. A method for inhibiting the proliferation of arterial smooth muscle cells following angioplasty which comprises the steps of:

1. Conducting an angioplasty using a catheter with an expansible balloon to expand at least a portion of a plaque body and removing the catheter,

2. Inserting into the artery a catheter comprising a main catheter body having means including two spaced balloon elements adapted to be positioned ajacent respective proximate and distal ends of the original site of the plaque body and to hold said main catheter body in place and expansible against the arterial walls for providing a chamber about said site, and means carried by said main catheter body for delivering heparin into said chamber,

3. Inflating said two spaced balloon elements, to form a chamber at the site of the angioplasty,

4. Delivering heparin into said chamber through said heparin delivering means under a pressure of 200 to 1000 mmHg at the site of the angioplasty whereby the heparin sticks to and penetrates the adjacent arterial tissue defined by the chamber,

5. Deflating said two spaced balloon elements, and

6. Removing the catheter from the artery.

2. A method as in claim 1 wherein the angioplasty is percutaneous transluminal coronary angioplasty.

4. A method as in claim 2 wherein the angioplasty is percutaneous transluminal coronary angioplasty.

3. A method for relieving an arterial constriction caused by a body of plaque and therafter inhibiting the proliferation of smooth muscle cells at the site of the plaque which comprises the steps of:

1. Inserting into the artery a chateter comprising a main catheter body having means including two spaced balloon elements adapted to be positioned adjacent respective proximate and distal ends of the plaque body and expansible against the arterial walls for providing a chamber about said plaque body and to hold said main catheter body in place, means carried by said main catheter body for delivering heparin into said chamber, and means including a third expansible balloon element disposed intermediate said two spaced balloon elements,

2. Inflating said third balloon element against said plaque body to perform an angioplasty and to expand at least a portin of the plaque body,

3. Deflating said third balloon element,

4. Inflating said two spaced balloon elements to form a chamber at the site of the angioplasty,

5. Delivering heparin into said chamber through said heparin delivering means under a pressure of 200 to 1000 mmHg at the site of the angioplasty whereby the heparin sticks to and penetrates the adjacent arterial tissue defined by the chamber,

6. Deflating said two spaced balloon elements, and

7. Revmoving the catheter from the artery.

5. A method for inhibiting the proliferation of arterial smooth muscle cells following angioplasty which comprises the steps of:

1. Conducting an angioplasty and,

2. Depositing heparin under a pressure of 200 to 1000 mmHg at the site of the angioplasty utilizing heparin depositing means, whereby the heparin sticks to and penetrates the arterial tissue in and adjacent to the angioplasty site.

6. A method for inhibiting the proliferation of arterial smooth muscle cells following angioplasty which comprises the steps of:

1. Conducting an angioplasty using a catheter with an expansible balloon to expand at least a portion of the plaque body thereby creating a lesion site, and

2. Depositing heparin under a pressure of 200 to 1000 mmHg at the lesion site of the angioplasty utilizing heparin depositing means, whereby the heparin sticks to and penetrates the arterial tissue of the lesion site and adjacent thereto.